A citation-based method for searching scientific literature

Aeron C Hurt, David S Hui, Alan Hay, Frederick G Hayden. Influenza Other Respir Viruses 2015
Times Cited: 12







List of co-cited articles
75 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Stella G Muthuri, Sudhir Venkatesan, Puja R Myles, Jo Leonardi-Bee, Tarig S A Al Khuwaitir, Adbullah Al Mamun, Ashish P Anovadiya, Eduardo Azziz-Baumgartner, Clarisa Báez, Matteo Bassetti,[...]. Lancet Respir Med 2014
380
33

A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection.
Ronald B Moss, Carrie Hansen, Rebecca L Sanders, Stephen Hawley, Tiejun Li, Roy T Steigbigel. J Infect Dis 2012
85
33

The molecular basis of the specific anti-influenza action of amantadine.
A J Hay, A J Wolstenholme, J J Skehel, M H Smith. EMBO J 1985
606
25

Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Giuseppe Belardo, Orlando Cenciarelli, Simone La Frazia, Jean Francois Rossignol, M Gabriella Santoro. Antimicrob Agents Chemother 2015
55
25

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
Joanna Dobson, Richard J Whitley, Stuart Pocock, Arnold S Monto. Lancet 2015
291
25

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
Anthony E Fiore, Alicia Fry, David Shay, Larisa Gubareva, Joseph S Bresee, Timothy M Uyeki. MMWR Recomm Rep 2011
516
25

Nitazoxanide: a first-in-class broad-spectrum antiviral agent.
Jean-François Rossignol. Antiviral Res 2014
241
25

Oral GS-5806 activity in a respiratory syncytial virus challenge study.
John P DeVincenzo, Richard J Whitley, Richard L Mackman, Cecilia Scaglioni-Weinlich, Lisa Harrison, Eric Farrell, Stephen McBride, Robert Lambkin-Williams, Robert Jordan, Yan Xin,[...]. N Engl J Med 2014
225
25

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial.
Jason Haffizulla, Aaron Hartman, Melanie Hoppers, Harvey Resnick, Steve Samudrala, Christine Ginocchio, Matthew Bardin, Jean-François Rossignol. Lancet Infect Dis 2014
132
25

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
John Mair-Jenkins, Maria Saavedra-Campos, J Kenneth Baillie, Paul Cleary, Fu-Meng Khaw, Wei Shen Lim, Sophia Makki, Kevin D Rooney, Jonathan S Nguyen-Van-Tam, Charles R Beck. J Infect Dis 2015
543
25

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets.
Robert H E Friesen, Wouter Koudstaal, Martin H Koldijk, Gerrit Jan Weverling, Just P J Brakenhoff, Peter J Lenting, Koert J Stittelaar, Albert D M E Osterhaus, Ronald Kompier, Jaap Goudsmit. PLoS One 2010
78
25

Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A.
Priyanka Gupta, Amrita V Kamath, Summer Park, Henry Chiu, Jeff Lutman, Mauricio Maia, Man-Wah Tan, Min Xu, Lee Swem, Rong Deng. MAbs 2016
32
25

DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.
Jessica A Belser, Xiuhua Lu, Kristy J Szretter, Xiaoping Jin, Laura M Aschenbrenner, Alice Lee, Stephen Hawley, Do Hyong Kim, Michael P Malakhov, Mang Yu,[...]. J Infect Dis 2007
89
25


Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.
Michael P Malakhov, Laura M Aschenbrenner, Donald F Smee, Miles K Wandersee, Robert W Sidwell, Larisa V Gubareva, Vasiliy P Mishin, Frederick G Hayden, Do Hyong Kim, Alice Ing,[...]. Antimicrob Agents Chemother 2006
144
25

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
Michael P Clark, Mark W Ledeboer, Ioana Davies, Randal A Byrn, Steven M Jones, Emanuele Perola, Alice Tsai, Marc Jacobs, Kwame Nti-Addae, Upul K Bandarage,[...]. J Med Chem 2014
121
25

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
Gallen B Triana-Baltzer, Larisa V Gubareva, John M Nicholls, Melissa B Pearce, Vasiliy P Mishin, Jessica A Belser, Li-Mei Chen, Renee W Y Chan, Michael C W Chan, Maria Hedlund,[...]. PLoS One 2009
76
25

Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.
Jean François Rossignol, Simone La Frazia, Lucia Chiappa, Alessandra Ciucci, M Gabriella Santoro. J Biol Chem 2009
150
25

Newer influenza antivirals, biotherapeutics and combinations.
Frederick G Hayden. Influenza Other Respir Viruses 2013
48
16

Drugs in development for influenza.
David A Boltz, Jerry R Aldridge, Robert G Webster, Elena A Govorkova. Drugs 2010
85
16

Neuraminidase inhibitors for influenza.
Anne Moscona. N Engl J Med 2005
705
16

Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.
Gallen B Triana-Baltzer, Rebecca L Sanders, Maria Hedlund, Kellie A Jensen, Laura M Aschenbrenner, Jeffrey L Larson, Fang Fang. J Antimicrob Chemother 2011
38
16

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.
Jonathan Hsu, Nancy Santesso, Reem Mustafa, Jan Brozek, Yao Long Chen, Jessica P Hopkins, Adrienne Cheung, Gayane Hovhannisyan, Liudmila Ivanova, Signe A Flottorp,[...]. Ann Intern Med 2012
164
16

Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay.
Aruna D Balgi, Jun Wang, Daphne Y H Cheng, Chunlong Ma, Tom A Pfeifer, Yoko Shimizu, Hilary J Anderson, Lawrence H Pinto, Robert A Lamb, William F DeGrado,[...]. PLoS One 2013
39
16


Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.
Michael T Osterholm, Nicholas S Kelley, Alfred Sommer, Edward A Belongia. Lancet Infect Dis 2012
16

Reconstruction of the 1918 influenza virus: unexpected rewards from the past.
Jeffery K Taubenberger, David Baltimore, Peter C Doherty, Howard Markel, David M Morens, Robert G Webster, Ian A Wilson. mBio 2012
43
16




Antiviral combinations for severe influenza.
Jake Dunning, J Kenneth Baillie, Bin Cao, Frederick G Hayden. Lancet Infect Dis 2014
110
16

DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation.
S Chalkias, M R Mackenzie, C Gay, C Dooley, F M Marty, R B Moss, T Li, R L Routh, S R Walsh, C S Tan. Transpl Infect Dis 2014
27
16

Human infection with influenza virus A(H10N8) from live poultry markets, China, 2014.
Tao Zhang, Yuhai Bi, Huaiyu Tian, Xiaowen Li, Di Liu, Ying Wu, Tao Jin, Yong Wang, Quanjiao Chen, Ze Chen,[...]. Emerg Infect Dis 2014
65
16

Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.
Alimuddin Zumla, Ziad A Memish, Markus Maeurer, Matthew Bates, Peter Mwaba, Jaffar A Al-Tawfiq, David W Denning, Frederick G Hayden, David S Hui. Lancet Infect Dis 2014
68
16

Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.
Alpana Waghmare, Thor Wagner, Robert Andrews, Sherilyn Smith, Jane Kuypers, Michael Boeckh, Ronald Moss, Janet A Englund. J Pediatric Infect Dis Soc 2015
34
16

Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial.
Seizaburo Kashiwagi, Akira Watanabe, Hideyuki Ikematsu, Shinichiro Awamura, Takako Okamoto, Mitsutoshi Uemori, Katsuyasu Ishida. J Infect Chemother 2013
22
16

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
Adam Meijer, Helena Rebelo-de-Andrade, Vanessa Correia, Terry Besselaar, Renu Drager-Dayal, Alicia Fry, Vicky Gregory, Larisa Gubareva, Tsutomu Kageyama, Angie Lackenby,[...]. Antiviral Res 2014
61
16


Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure.
Kannan Tharakaraman, Vidya Subramanian, David Cain, Viswanathan Sasisekharan, Ram Sasisekharan. Cell Host Microbe 2014
42
16

Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza.
Eleanor L Ramos, Jennifer L Mitcham, Teri D Koller, Aurelio Bonavia, Dale W Usner, Ganesh Balaratnam, Paul Fredlund, Kristine M Swiderek. J Infect Dis 2015
89
16

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks.
Andrew M Wollacott, Maciej F Boni, Kristy J Szretter, Susan E Sloan, Mona Yousofshahi, Karthik Viswanathan, Sylvain Bedard, Catherine A Hay, Patrick F Smith, Zachary Shriver,[...]. EBioMedicine 2016
37
16

A highly conserved neutralizing epitope on group 2 influenza A viruses.
Damian C Ekiert, Robert H E Friesen, Gira Bhabha, Ted Kwaks, Mandy Jongeneelen, Wenli Yu, Carla Ophorst, Freek Cox, Hans J W M Korse, Boerries Brandenburg,[...]. Science 2011
591
16

Neuraminidase inhibitors for preventing and treating influenza in adults and children.
Tom Jefferson, Mark A Jones, Peter Doshi, Chris B Del Mar, Rokuro Hama, Matthew J Thompson, Elizabeth A Spencer, Igho Onakpoya, Kamal R Mahtani, David Nunan,[...]. Cochrane Database Syst Rev 2014
311
16

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.
Andres G Grandea, Ole A Olsen, Thomas C Cox, Mark Renshaw, Philip W Hammond, Po-Ying Chan-Hui, Jennifer L Mitcham, Witold Cieplak, Shaun M Stewart, Michael L Grantham,[...]. Proc Natl Acad Sci U S A 2010
95
16

Nitazoxanide: a new broad spectrum antiparasitic agent.
Clinton A White. Expert Rev Anti Infect Ther 2004
75
16

The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study.
S Y Mir-Shekari, D A Ashford, D J Harvey, R A Dwek, I T Schulze. J Biol Chem 1997
84
16

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.
Davide Corti, Jarrod Voss, Steven J Gamblin, Giosiana Codoni, Annalisa Macagno, David Jarrossay, Sebastien G Vachieri, Debora Pinna, Andrea Minola, Fabrizia Vanzetta,[...]. Science 2011
817
16

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
Emi Takashita, Miho Ejima, Rie Ogawa, Seiichiro Fujisaki, Gabriele Neumann, Yousuke Furuta, Yoshihiro Kawaoka, Masato Tashiro, Takato Odagiri. Antiviral Res 2016
38
16

An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality.
Henju Marjuki, Vasiliy P Mishin, Anton P Chesnokov, Juan A De La Cruz, Alicia M Fry, Julie Villanueva, Larisa V Gubareva. J Infect Dis 2014
37
16

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
D R Drozd, A P Limaye, R B Moss, R L Sanders, C Hansen, J D Edelman, G Raghu, M Boeckh, R M Rakita. Transpl Infect Dis 2013
38
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.